BMO Capital Downgrades TrueBlue (TBI) to Market Perform
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $9.21 --0%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 36
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 36
Join SI Premium – FREE
BMO Capital downgraded TrueBlue (NYSE: TBI) from Outperform to Market Perform with a price target of $26.00 (from $35.00).
For an analyst ratings summary and ratings history on TrueBlue click here. For more ratings news on TrueBlue click here.
Shares of TrueBlue closed at $22.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ionis Pharmaceuticals (IONS) PT Lowered to $70 at JPMorgan Amid Negative Sentiment
- Kepler Cheuvreux Downgrades Landsec (LAND:LN) to Hold
- Astra International Tbk PT (ASII:IJ) (PTAIY) PT Lowered to IDR6,450 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
